GM6 and the Blood-Brain-Barrier

GM6 binds rapidly and remains bound in vivo after 4 hours.

GM6 has a good brain-to-plasma ratio (1.65) in biomimetics measurement.
GM6 rapidly transits the blood-brain barrier enabling neuron survival through developmental-stage pathways: reducing inflammation, decreasing oxidative stress, reducing plaque formation, increasing growth factor, and decreasing apoptosis in the central and peripheral nervous systems.